Natasa Gisev
Biographic Data
| ID | 7446889 |
|---|---|
| NAME | Natasa Gisev |
| GIVEN NAMES | Natasa |
| FAMILY NAME | Gisev |
| SIGNATURE | GISEV N |
| AFFILIATIONS | UNSW Sydney |
| ORCID | 0000-0003-0452-8470 |
| VERIFIED | Yes |
| TOTAL WORKS | 13 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 13 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2013 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
Trends in prescription opioid analgesic use in Australia from 2015 to 2022
Prescribed opioid analgesic use declined between 2015 and 2022 because of reductions in PBS dispensing claims. A quarter of the reduction in PBS dispensing claims was offset by use outside the PBS. Our findings indicate a significant increase in private use, reasons for which may include accessing opioids not PBS-subsidised and circumventing PBS restrictions for PBS-subsidised opioids. Comparing multiple data sources provides a comprehensive acco…
‘We didn't cause the opioid epidemic’
Prevalence of comorbid substance use disorders among people with opioid use disorder
Prescription opioid use among people with opioid dependence and concurrent benzodiazepine and gabapentinoid exposure
The increased mortality risk associated with benzodiazepines and gabapentinoids among PWOD appear to be reduced when engaged in OAT. A greater focus on encouraging OAT engagement, providing overdose prevention education, and access and coverage of overdose antidotes is necessary to minimise the unintended consequences of medicines use in this population
Trends in use of medicines for opioid agonist treatment in Australia, 2013–2022
Patterns of OAT have shifted over the last 10-years with buprenorphine (SL/LAI) now the most common OAT used in Australia. The introduction of LAI buprenorphine has expanded OAT access, particularly in non-community pharmacy settings, and in remote areas
Mortality during and after specialist alcohol and other drug treatment
Opioid prescribing patterns among medical practitioners in New South Wales, Australia
Trends in transdermal fentanyl utilisation and fatal fentanyl overdose across Australia (2003–2015)
Age at first alcohol‐related hospital separation or emergency department presentation and rate of re‐admission
Self-reported challenges obtaining ongoing prescription opioids among Australians with chronic non-cancer pain
Patterns and correlates of prescribed and non‐prescribed pregabalin use among a sample of people who inject drugs in Australia
Offending, custody and opioid substitution therapy treatment utilisation among opioid-dependent people in contact with the criminal justice system
Compared to non-Indigenous opioid-dependent people, Indigenous opioid-dependent people in contact with the criminal justice system are charged with a greater number of offences, spend longer in custody and commonly initiate OST in prison. Hence, contact with the criminal justice system provides an important opportunity to engage Indigenous people in OST
Interrater agreement and interrater reliability
No prominent works on this page.
Interrater agreement and interrater reliability
Offending, custody and opioid substitution therapy treatment utilisation among opioid-dependent people in contact with the criminal justice system
Compared to non-Indigenous opioid-dependent people, Indigenous opioid-dependent people in contact with the criminal justice system are charged with a greater number of offences, spend longer in custody and commonly initiate OST in prison. Hence, contact with the criminal justice system provides an important opportunity to engage Indigenous people in OST
Patterns and correlates of prescribed and non‐prescribed pregabalin use among a sample of people who inject drugs in Australia
Trends in transdermal fentanyl utilisation and fatal fentanyl overdose across Australia (2003–2015)
Age at first alcohol‐related hospital separation or emergency department presentation and rate of re‐admission
Self-reported challenges obtaining ongoing prescription opioids among Australians with chronic non-cancer pain
Mortality during and after specialist alcohol and other drug treatment
Opioid prescribing patterns among medical practitioners in New South Wales, Australia
‘We didn't cause the opioid epidemic’
Prevalence of comorbid substance use disorders among people with opioid use disorder
Prescription opioid use among people with opioid dependence and concurrent benzodiazepine and gabapentinoid exposure
The increased mortality risk associated with benzodiazepines and gabapentinoids among PWOD appear to be reduced when engaged in OAT. A greater focus on encouraging OAT engagement, providing overdose prevention education, and access and coverage of overdose antidotes is necessary to minimise the unintended consequences of medicines use in this population
Trends in use of medicines for opioid agonist treatment in Australia, 2013–2022
Patterns of OAT have shifted over the last 10-years with buprenorphine (SL/LAI) now the most common OAT used in Australia. The introduction of LAI buprenorphine has expanded OAT access, particularly in non-community pharmacy settings, and in remote areas
Trends in prescription opioid analgesic use in Australia from 2015 to 2022
Prescribed opioid analgesic use declined between 2015 and 2022 because of reductions in PBS dispensing claims. A quarter of the reduction in PBS dispensing claims was offset by use outside the PBS. Our findings indicate a significant increase in private use, reasons for which may include accessing opioids not PBS-subsidised and circumventing PBS restrictions for PBS-subsidised opioids. Comparing multiple data sources provides a comprehensive acco…
Medicine (10 works) · Internal Medicine (9 works) · Opioid Use Disorder Treatment (8 works) · Opioid (6 works) · Psychiatry (6 works) · Pain Management and Opioid Use (5 works) · Anesthesia (4 works) · Cohort (4 works) · Substance Abuse Treatment and Outcomes (4 works) · Demography (3 works)